Multiple Myeloma: Choosing the best treatment regimen in patients with high-risk cytogenetics - Part 3

December 06, 2023 00:19:56
Multiple Myeloma: Choosing the best treatment regimen in patients with high-risk cytogenetics - Part 3
COR2ED - Oncology Medical Conversation
Multiple Myeloma: Choosing the best treatment regimen in patients with high-risk cytogenetics - Part 3

Dec 06 2023 | 00:19:56

/

Show Notes

In this podcast episode, myeloma experts Dr. María Victoria Mateos (Haematologist at the University Hospital Salamanca, Spain) and Dr. Alexander Lesokhin (Associate Attending on the Myeloma Service at the Memorial Sloan Kettering Cancer Center, New York, NY, USA) discuss how they choose the best treatment regimen for patients with multiple myeloma and a high-risk cytogenetic profile. 

Firstly, they discuss the treatment options available for patients with high-risk cytogenetics in the US and in Europe. However, the key question is how to decide, for each individual, which treatment option is the best one. Dr. Mateos and Dr. Lesokhin discuss the factors they consider in these decisions in their clinical practice. Although the prior treatment is the most important consideration in the relapsed setting, the type of cytogenetic abnormality also plays a role. The experts specifically discuss treatment decisions in patients with extramedullary multiple myeloma: a difficult-to-treat population.

The speakers also discuss the future of myeloma treatment. How should trial design be adapted to better meet the needs of patients with a high-risk cytogenetic profile? What will be the role of CAR-T and bispecific antibodies in this population?

The experts conclude by summarising their key take-aways from the discussion.

Other Episodes

Episode

December 06, 2023 00:13:19
Episode Cover

HCC: Highlights from ILCA and ESMO 2021

Professor Matthias Pinter, medical hepatologist from the medical University of Vienna in Austria shares some insights from key abstracts and topics discussed at ILCA...

Listen

Episode

November 25, 2024 00:23:25
Episode Cover

Testing to treatment of BRAF-mutant metastatic NSCLC

 Testing to treatment of BRAF-mutant metastatic NSCLC    In this educational podcast episode, experts Prof. David Planchard and Dr Federico Cappuzzo discuss the significance of...

Listen

Episode

December 06, 2023 00:26:17
Episode Cover

Breast cancer: Oral SERDs in ER+ BC. Part 3 - Rare cases & treatment challenges

In this final episode, the experts discuss two patient case studies with oral SERDs (oral selective estrogen receptor degraders) and a novel therapy for...

Listen